The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) serves as a catalyst to stimulate greater levels of collaborative engagement among member organizations’ work on key lung cancer issues. The work of the ACS NLCRT is guided by its strategic plan with direction and input from its active and engaged Steering Committee. Through the efforts of its strategic priority Task Groups, the ACS NLCRT advances initiatives that focus on provider engagement and outreach, tobacco treatment in the context of lung cancer screening, shared decision-making about screening and treatment, lung cancer in women, implementation of screening programs, access to high-quality screening, policy action, triage for appropriate diagnostic evaluation and therapy, and an end to the stigma and nihilism associated with a diagnosis of lung cancer, which pervades every aspect of this disease.

A fundamental premise of the ACS NLCRT is that collective action among the member organizations will be more successful in reducing the burden of disease and reducing that burden faster. A core principle of the ACS NLCRT is that it will not duplicate or take on roles of member organizations, but rather we seek to enhance the contributions of member organizations to lung cancer care and control through greater engagement with other key organizations, as well as to take on initiatives that all organizations would judge to be worthy but would be unlikely to initiate on their own.

Together, members work to share information, identify needs and opportunities, and address gaps in research, programs, activities, and services relating to lung cancer. The strength of such a partnership, united in mission, enhances the work of each member and furthers the cause of lung cancer risk reduction, early detection, and diagnosis and treatment in the United States.